Effect of biphasic insulin aspart 30/70 (BIAsp30) in combination with metformin on glycaemic control in subjects with type 2 diabetes not optimally controlled on oral antidiabetic agents

被引：0

作者：

Naiker, P.

Makan, H. A.

Omar, M. A. K.

Kedijang, T.

Kong, L. L. L.

机构：

[1] St Augustines Hosp, Durban, South Africa

[2] Novo Nordisk, Johannesburg, South Africa

[3] Novo Nordisk, Singapore, Singapore

来源：

DIABETOLOGIA | 2006年 / 49卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

0983

引用

页码：599 / 600

页数：2

共 50 条

[1] Optimising glycaemic control with BIAsp30 (once or twice daily) in combination with oral antidiabetic agents in type 2 diabetes
Suwanwalaikorn, S
DIABETOLOGIA, 2005, 48 : A308 - A308
[2] Effect of BIAsp 30 (biphasic insulin aspart 30) in combination with oral hypoglycaemic agents on glycaemic regulation in non-obese patients with type 2 diabetes
Lund, S. S.
Tarnow, L.
Nielsen, B. B.
Hansen, B. V.
Pedersen, O.
Parving, H. -H.
Vaag, A. A.
DIABETOLOGIA, 2006, 49 : 600 - 600
[3] Biphasic insulin aspart 30/70 (BIAsp 30) in the treatment of type 1 and type 2 diabetes
Valensi, Paul
DIABETES METABOLIC SYNDROME AND OBESITY, 2009, 2 : 61 - 71
[4] Biphasic Insulin Aspart 30 (BIAsp 30) is Safe and Improves Glycaemic Control in Insulin Naive Patients with Type 2 Diabetes
Esteghamati, Alireza
Nakhjavani, Manouchehr
Aminorroaya, Ashraf
Aboutorabi, Robabeh
Niafar, Mitra
Mohammadi, Mohammad
Parvaresh, Ehsan
JOURNAL OF DIABETES & METABOLISM, 2011, 2 (03)
[5] Effect of biphasic insulin aspart 30 combined with metformin on glycaemic control in obese people with type 2 diabetes
Ascic-Buturovic, Belma
BOSNIAN JOURNAL OF BASIC MEDICAL SCIENCES, 2007, 7 (04) : 335 - 338
[6] In patients with poorly controlled Type 2 diabetes, biphasic insulin aspart 30 combined with metformin provides better glycaemic control than sulphonylurea/metformin combination
Kvapil, M
Mikolajczyk-Swatko, A
Ostergaard, AH
Shestakova, M
DIABETOLOGIA, 2002, 45 : A18 - A18
[7] Comparison of twice-daily biphasic insulin aspart 70/30 (BIAsp 70/30) with once-daily insulin glargine (GLA) in patients with type 2 DM on oral antidiabetic agents
Raskin, P
Rojas, P
Allen, E
DIABETES, 2004, 53 : A143 - A143
[8] Effect of BIAsp30 (NovoLog® mix 70/30) in combination with oral hypoglycaemic agents (ORA) on glycaemic control in non-obese patients with type-2 diabetes (T2DM)
Lund, SS
Tarnow, L
Pedersen, OB
Parving, HH
Vaag, AA
DIABETES, 2005, 54 : A126 - A126
[9] Biphasic insulin aspart 30 plus metformin: an effective combination in type 2 diabetes
Kvapil, A
Swatko, A
Hilberg, C
Shestakova, A
DIABETES OBESITY & METABOLISM, 2006, 8 (01): : 39 - 48
[10] Comparison of biphasic insulin aspart (BIAsp30) and insulin glargine (IGlarg) during isoglycaemic clamp studies in persons with type 2 diabetes
Luzio, SD
Peter, R
Dunseath, GJ
Pauvaday, V
Owens, DR
DIABETES, 2004, 53 : A136 - A136

← 1 2 3 4 5 →